Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy

Keita Tamura, Ryosuke Ando, Kiyoshi Takahara, Toshiki Ito, Kent Kanao, Takahiro Yasui, Ryoichi Shiroki, Hideaki Miyake

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences